QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

22,437 signal articles · 89 in last 24h · 107,740 total before filter · latest 43m ago
89last 24h
2559last 7d
493● bullish (7d)
237● bearish (7d)
201publishers
AllMacro215Earnings1595M&A122Regulatory16Product10Analyst25
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Investing.com74d agoneutral
Quantinuum targets $12.7 billion valuation in U.S. IPO

Investing.com -- Honeywell's spinoff Quantinuum plans to raise up to $1.05 billion through a U.S. initial public offering that would value the quantum computing company at up to $12.7 billion, the firm announced on Tuesday.

The Question About Elon Musk That SpaceX Refuses to Answer Before Its IPO
24/7 Wall St.74d agoneutral
The Question About Elon Musk That SpaceX Refuses to Answer Before Its IPO

There’s a question floating around the biggest IPO in history, and SpaceX has chosen its words very carefully to avoid answering it. I’ve been reading pre-IPO paperwork for nearly two decades, and what’s missing from this one tells you more than what’s in it. The company is reportedly heading to NASDAQ in June 2026 at ... The Question About Elon Musk That SpaceX Refuses to Answer Before Its IPO

Bloomberg74d agoneutral
Honeywell-Backed Quantinuum Seeks to Raise $1.05 Billion in IPO

(Bloomberg) -- Quantinuum Inc., a quantum computing company backed by Honeywell International Inc., is seeking to raise $1.05 billion in its US initial public offering, capitalizing on investor enthusiasm for the technology. Most Read from BloombergNvidia CEO Urges Super Micro to Tighten Up on ComplianceTrump Doctor Visit Renews Health Scrutiny as 80th Birthday NearsTrump Says He’ll Announce Negotiated Deal With Iran ShortlyRubio Sees Good News Coming on Hormuz as Iran Talks ContinueUS, Iran Inc

Honeywell's Quantinuum targets $12.7 billion valuation in US IPO
Reuters74d agoneutral
Honeywell's Quantinuum targets $12.7 billion valuation in US IPO

Honeywell's Quantinuum is targeting a valuation of up ‌to $12.7 billion in its U.S. initial ‌public offering, it said on Tuesday, as ​it looks to capitalize on heightened investor attention around quantum computing. It had raised ⁠funds at a valuation of $10 billion in its latest funding round. Quantinuum, formed in 2021 after a separation from Honeywell and merger ‌with Cambridge Quantum, is ​chaired by the industrial ​giant's CEO, ​Vimal Kapur, and led ‌by Intel veteran Rajeeb Hazra.

Analysis-SpaceX debut draws a crowd, but few recent hot IPOs outpace the market
Reuters75d agoneutral
Analysis-SpaceX debut draws a crowd, but few recent hot IPOs outpace the market

Wall Street is abuzz with next month's expected blockbuster debut of Elon Musk's rocket and satellite maker SpaceX, but few of the biggest IPOs in recent years have paid off for investors who bought in when the deals came to market. A Reuters analysis ‌of the 50 IPOs with the highest valuations in the past five years shows that investors would have been better off buying an S&P 500 ‌index fund about three-quarters of the time. An investor who bought each of the IPOs tracked ​by Reuters would be up an average of 27% through May 21.

AvalonBay (AVB) and Equity Residential Near Merger Agreement
Insider Monkey75d agoneutral
AvalonBay (AVB) and Equity Residential Near Merger Agreement

AvalonBay Communities, Inc. (NYSE:AVB) is one of the 10 Best Residential REITs to Buy in 2026. On May 20, 2026, Bloomberg reported that AvalonBay Communities, Inc. (NYSE:AVB) and Equity Residential are nearing a potential merger agreement that would combine two of the largest REITs by market value. AvalonBay currently has a market capitalization of about […]

Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio
Insider Monkey75d agoneutral
Gilead Sciences (GILD) Acquires Tubulis for $3.15B to Expand Oncology Portfolio

Gilead Sciences Inc. (NASDAQ:GILD) is one of the cheap NASDAQ stocks to buy right now. On May 21, Gilead Sciences completed the acquisition of Tubulis GmbH, a Germany-based biotechnology company, for $3.15 billion in upfront payments plus up to $1.85 billion in potential milestone considerations. This strategic move bolsters Gilead’s oncology portfolio by integrating Tubulis’ […]

Chart Industries Merger Review Highlights Valuation And Regulatory Uncertainty
Simply Wall St.76d agoneutral
Chart Industries Merger Review Highlights Valuation And Regulatory Uncertainty

Chart Industries, Inc. (NYSE:GTLS) is progressing with its planned merger with Baker Hughes as the European Commission starts a Phase I antitrust review. The company confirmed that regulatory clearance in Europe is a key condition for closing the deal. Chart Industries also highlighted the potential for timing delays and the possibility that the transaction could be terminated if approvals are not obtained. Chart Industries focuses on equipment and solutions for liquefied natural gas,...

Chipotle rival Mexican chain closes all U.S. restaurants
TheStreet76d agoneutral
Chipotle rival Mexican chain closes all U.S. restaurants

For many Americans, eating out has become a luxury. Some people have been trading down, while others have decided to eat at home more often. In my decades of covering restaurants, I've never seen a period where consumers have been hit by both high prices and a challenging economy. Even some ...